The latest thoracic oncology news
A meta-analysis of phase III trials suggests that chemoimmunotherapy may provide superior overall survival and…
Adjuvant treatment with the targeted therapy drug selpercatinib can help reduce the risk that cancer…
The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favourable safety…
Treatment with the investigational next-generation KRAS-G12C inhibitor elisrasib led to clinical benefit in patients with…
New findings have identified a potential association between COVID-19 and increased lung cancer risk, driven…
A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response…
In a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research,…
A retrospective cohort study published in JAMA Network Open has evaluated whether non-invasive measures of…
Most peripheral pulmonary lesions are benign, yet the malignant minority represents the leading cause of…
Scientists have discovered how cancer cells can exploit healthy lung cells to support metastatic tumour growth in the lungs. In two…